Dan Rubin is President and CEO of PARx Solutions.
Does Formulary Contracting = Patients Will Get Their Prescriptions?
A look at the communication disconnect between contracting with managed care plans and pharmaceutical benefit managers (PBMs) and the imposition and implications of prior authorization (PA) requirements.
Generating High PA Approval Rates: Important But Not Sufficient
Brands that wish to overcome prior authorization (PA) challenges should work with service providers that generate high approvals on submitted PAs and drive more submissions from prescribers, writes Dan Rubin.
Tackling the Prior Authorization Challenge: A Critical Task for Pharma
Effectively addressing prior authorization challenges as part of a company’s core sales and marketing tactics can yield tangible and substantial benefits, writes Dan Rubin.